Peter has always had a passion for pharmaceutical innovation. Peter graduated from Oxford in 2003 with a first class degree in Chemistry, following which he trained and qualified as a UK and European patent attorney specializing in pharmaceuticals.
In 2008 Peter joined Teva, a generic drug giant, to work directly with pharmaceutical formulation teams. Peter left Teva in 2011 to return to private practice with AmLaw 100 firm Mintz Levin, where he advised start-up and mid-cap innovative pharma firms on IP and legal matters. He left Mintz Levin in 2015 to set up Small Pharma.